Previous Close | 96.14 |
Open | 96.30 |
Bid | 0.00 x 1300 |
Ask | 0.00 x 1300 |
Day's Range | 94.90 - 96.72 |
52 Week Range | 62.11 - 99.91 |
Volume | |
Avg. Volume | 1,893,988 |
Market Cap | 24.292B |
Beta (5Y Monthly) | 1.22 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -9.67 |
Earnings Date | Aug 05, 2024 - Aug 09, 2024 |
Forward Dividend & Yield | 1.60 (1.66%) |
Ex-Dividend Date | Jun 21, 2024 |
1y Target Est | 96.17 |
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
IFF (NYSE: IFF), a global leader in food and beverage, home and personal care and health will unveil groundbreaking study results at upcoming major biomedical conferences. These results highlight how IFF Pharma Solutions NovaMatrix® portfolio of ultrapure alginate biopolymers could revolutionize regenerative medicine and 3D cell culture applications. At the 12th World Biomaterials Congress (WBC), IFF Pharma Solutions will showcase a first-of-its-kind alginate hydrogel system that self-gels, offe
International Flavors (IFF) gains from its strategic actions and focus on growth.